title: Toward Development of Psychosocial Measures for Automated Insulin Delivery.
abstract: The INSPIRE study working group launched its initial workshop in February 2015 to facilitate collaboration among key stakeholders interested in automated insulin delivery (AID) systems and the psychosocial outcomes of individuals who may use these new technologies. Specifically, the INSPIRE team's goal is to facilitate measure development assessing the psychosocial factors associated with AID systems. A second working group was held to foster exchange among key stakeholders in AID system development. Patient, health care provider, engineering, industry, academic, regulatory and payer perspectives were presented. The INSPIRE working group will continue to serve as a platform to encourage open dialogue among all stakeholders with the aim of facilitating technology that offers minimal user burden and maximum benefit from both a psychological and physiologic perspective.
authors.affiliation: Ann and Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, IL, USA jwbenchell@luriechildrens.org.
authors.forename: Jill
authors.initials: J
authors.lastname: Weissberg-Benchell
authors.affiliation: Pediatrics, Psychiatry and Behavioral Sciences, Stanford University, San Francisco, CA, USA.
authors.forename: Korey
authors.initials: K
authors.lastname: Hood
authors.affiliation: Joslin Diabetes Center, Harvard Medical School, Boston, MA, USA.
authors.forename: Lori
authors.initials: L
authors.lastname: Laffel
authors.affiliation: Science & Co, Dusseldorf, Germany and San Diego, CA, USA.
authors.forename: Lutz
authors.initials: L
authors.lastname: Heinemann
authors.affiliation: T1D Exchange, Boston, MA.
authors.forename: Dana
authors.initials: D
authors.lastname: Ball
authors.affiliation: Juvenile Diabetes and Research Foundation, New York, NY, USA.
authors.forename: Aaron
authors.initials: A
authors.lastname: Kowalski
authors.affiliation: University of Southern California, Keck School of Medicine, Los Angeles, CA, USA.
authors.forename: Anne
authors.initials: A
authors.lastname: Peters
authors.affiliation: Department of Biomedical Engineering, Boston University, Boston, MA, USA.
authors.forename: Edward
authors.initials: E
authors.lastname: Damiano
authors.affiliation: Schiller Advisors, Wellesley, MA, USA.
authors.forename: Marie
authors.initials: M
authors.lastname: Schiller
authors.affiliation: Jupiter Life Science Consulting, San Clemente, CA, USA.
authors.forename: Aaron
authors.initials: A
authors.lastname: Davis
authors.affiliation: Food and Drug Administration, Washington, DC, USA.
authors.forename: Stayce
authors.initials: S
authors.lastname: Beck
authors.affiliation: Bournemouth University, Bournemouth, UK.
authors.forename: Katharine
authors.initials: K
authors.lastname: Barnard
mesh_terms: D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000188:drug therapy / Q000523:psychology*; D006801:Humans; D019397:Pancreas, Artificial / Q000523:psychology*; D011584:Psychology
keywords: artificial pancreas; automated insulin delivery; diabetes technology; human factors; psychosocial